5 year key figures
April 1 to March 31, in CHF million unless otherwise specified |
| 2020/21 |
| 2019/20 |
| 2018/19 |
| 2017/18 |
| 2016/17 |
|
Sales |
| 2,601.9 |
| 2,916.9 |
| 2,763.2 |
| 2,645.9 |
| 2,395.7 |
|
change compared to previous year (%) |
| (10.8) |
| 5.6 |
| 4.4 |
| 10.4 |
| 15.6 |
|
Gross profit |
| 1,873.5 |
| 2,083.6 |
| 1,966.2 |
| 1,868.2 |
| 1,651.8 |
|
in % of sales |
| 72.0 |
| 71.4 |
| 71.2 |
| 70.6 |
| 68.9 |
|
Gross profit (adjusted)1) |
| 1,880.2 |
| 2,106.9 |
| 1,975.1 |
| 1,868.2 |
| 1,651.8 |
|
in % of sales (adjusted) |
| 72.3 |
| 72.0 |
| 71.5 |
| 70.6 |
| 68.9 |
|
Research & development costs |
| 203.9 |
| 166.1 |
| 148.4 |
| 142.9 |
| 137.1 |
|
in % of sales |
| 7.8 |
| 5.7 |
| 5.4 |
| 5.4 |
| 5.7 |
|
Sales & marketing costs |
| 881.2 |
| 1,030.8 |
| 970.3 |
| 934.5 |
| 815.0 |
|
in % of sales |
| 33.9 |
| 35.3 |
| 35.1 |
| 35.3 |
| 34.0 |
|
Operating profit before acquisition-related amortization (EBITA) |
| 663.3 |
| 554.3 |
| 582.5 |
| 532.5 |
| 463.0 |
|
in % of sales |
| 25.5 |
| 19.0 |
| 21.1 |
| 20.1 |
| 19.3 |
|
Operating profit before acquisition-related amortization (EBITA) (adjusted)1) |
| 603.0 |
| 620.8 |
| 594.0 |
| 551.6 |
| 481.4 |
|
in % of sales (adjusted) |
| 23.2 |
| 21.2 |
| 21.5 |
| 20.8 |
| 20.1 |
|
Operating profit (EBIT) |
| 619.5 |
| 510.0 |
| 536.2 |
| 483.0 |
| 423.7 |
|
in % of sales |
| 23.8 |
| 17.5 |
| 19.4 |
| 18.3 |
| 17.7 |
|
Income after taxes |
| 585.3 |
| 489.5 |
| 460.2 |
| 407.4 |
| 356.2 |
|
in % of sales |
| 22.5 |
| 16.8 |
| 16.7 |
| 15.4 |
| 14.9 |
|
Income after taxes (adjusted)1) |
| 489.6 |
| 475.5 |
| 468.5 |
| 422.7 |
| 371.5 |
|
in % of sales (adjusted) |
| 18.8 |
| 16.2 |
| 17.0 |
| 16.0 |
| 15.5 |
|
Basic earnings per share |
| 9.23 |
| 7.61 |
| 6.98 |
| 6.13 |
| 5.35 |
|
Basic earnings per share (CHF) (adjusted)1) |
| 7.71 |
| 7.39 |
| 7.11 |
| 6.36 |
| 5.58 |
|
Dividend/distribution per share (CHF) |
| 3.202) |
| Stock Div. |
| 2.90 |
| 2.60 |
| 2.30 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash/(debt)3) |
| (83.3) |
| (663.0) |
| (253.9) |
| (228.0) |
| (404.6) |
|
Net working capital4) |
| 29.6 |
| (18.9) |
| 163.0 |
| 190.5 |
| 169.7 |
|
Capital expenditure (tangible and intangible assets)5) |
| 89.3 |
| 128.8 |
| 117.9 |
| 96.3 |
| 97.1 |
|
Capital employed6) |
| 2,855.7 |
| 2,692.5 |
| 2,630.0 |
| 2,702.9 |
| 2,535.9 |
|
Total assets |
| 5,925.6 |
| 4,486.5 |
| 4,292.5 |
| 4,302.0 |
| 3,935.7 |
|
Equity |
| 2,772.5 |
| 2,029.4 |
| 2,376.1 |
| 2,474.9 |
| 2,131.3 |
|
Equity financing ratio (%)7) |
| 46.8 |
| 45.2 |
| 55.4 |
| 57.5 |
| 54.2 |
|
Free cash flow8) |
| 571.9 |
| 563.7 |
| 346.9 |
| 360.0 |
| (232.6) |
|
Operating free cash flow9) |
| 602.4 |
| 638.5 |
| 411.8 |
| 419.2 |
| 424.8 |
|
Return on capital employed (%)10) |
| 22.3 |
| 18.2 |
| 20.6 |
| 18.4 |
| 20.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of employees (end of period) |
| 14,508 |
| 15,184 |
| 14,740 |
| 14,242 |
| 14,089 |
|
1)Non-GAAP financial measure adjusted for nonrecurring items; for details see the table “Reconciliation of non-GAAP financial measures" in the financial review or refer to the respective annual report.
2)Proposal to the Annual General Shareholders’ Meeting of June 15, 2021.
3)Cash and cash equivalents + other current financial assets (without loans) – current financial liabilities – current lease liabilities – non-current financial liabilities – non-current lease liabilities.
4)Receivables (incl. loans) + inventories – trade payables – current income tax liabilities – short-term contract liabilities – other short-term liabilities – short-term provisions.
5)Excluding goodwill and intangibles relating to acquisitions.
6)Equity – net cash/(debt).
7)Equity in % of total assets.
8)Cash flow from operating activities + cash flow from investing activities + payments for lease liabilities.
9)Free cash flow – cash consideration for acquisitions and from divestments, net of cash acquired/divested – cash consideration for associates.
10)EBIT in % of capital employed (average).